GlassScriptPhysician profile
Vani Duvuuri
NPI 1124063714
$9,985.28
in general payments reported to CMS, 2019-2025
45 companies · $2,110 in 2025
The $2,110 reported for 2025 was more than what 77% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,386 · 2020: $950 · 2021: $1,209 · 2022: $1,072 · 2023: $1,516 · 2024: $1,743 · 2025: $2,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,281 · Travel and Lodging: $1,019 · Gift: $59.40 · Education: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,280.86 |
| Travel and Lodging | $1,018.57 |
| Gift | $59.40 |
| Education | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,295.07 | 2021-2025 | Minimed 780g |
| Astrazeneca Pharmaceuticals LP | $999.84 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $823.70 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Mannkind Corporation | $795.60 | 2019-2025 | Afrezza |
| Novo Nordisk INC | $711.61 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $672.52 | 2019-2025 | Tepezza, Evenity, Prolia |
| Sanofi-Aventis U.S. LLC | $640.32 | 2019-2023 | |
| Dexcom, INC. | $521.48 | 2021-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $346.54 | 2020-2025 | Gvoke Hypopen |
| Insulet Corporation | $306.25 | 2021-2025 | Omnipod |
| Embecta Corp. | $267.08 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Merck Sharp & Dohme LLC | $252.63 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.78 | 2019-2025 | Jardiance |
| Amneal Pharmaceuticals LLC | $222.49 | 2019-2025 | Unithroid |
| Abbvie INC. | $185.06 | 2019-2025 | Synthroid |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $146.49 | 2019 | |
| Radius Health, INC. | $133.73 | 2019-2025 | Tymlos |
| Abbott Laboratories | $115.72 | 2021-2023 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $110.68 | 2022-2025 | |
| Corcept Therapeutics | $107.64 | 2019-2025 | Korlym |
| Amphastar Pharmaceuticals, INC. | $103.79 | 2025 | |
| Tandem Diabetes Care, INC. | $94.26 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ascendis Pharma Endocrinology INC | $91.66 | 2025 | Yorvipath |
| Sequel Med Tech, LLC | $70.35 | 2025 | Twiist |
| Beta Bionics, INC. | $69.89 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Alvogen INC | $63.30 | 2022-2025 | Teriparatide |
| Kvk-Tech, INC. | $62.30 | 2019 | |
| Ibsa Pharma INC. | $62.13 | 2019-2023 | Tirosint, Licart |
| Ascensia Diabetes Care US INC. | $59.23 | 2023-2025 | |
| Soleno Therapeutics, INC. | $57.84 | 2025 | Vykat Xr |
| Becton, Dickinson and Company | $52.38 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $41.35 | 2023-2024 | Crysvita, Crysvita |
| Amarin Pharma, INC. | $31.93 | 2019-2021 | |
| Cequr Corporation | $30.21 | 2022-2023 | Cequr Simplicity |
| Madrigal Pharmaceuticals | $29.39 | 2025 | Rezdiffra |
| Antares Pharma, INC. | $27.42 | 2021-2024 | Xyosted |
| Acella Pharmaceuticals, LLC | $21.27 | 2025 | NP Thyroid 60 |
| Novartis Pharmaceuticals Corporation | $20.96 | 2024 | |
| Lifescan, INC. | $20.80 | 2023 | |
| Esperion Therapeutics, INC. | $15.46 | 2021 | |
| Glaxosmithkline, LLC. | $14.24 | 2025 | Arexvy |
| Aytu Biopharma, INC. | $14.07 | 2020 | |
| Renalytix Ai, INC. | $13.92 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Zealand Pharma US, INC. | $12.45 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vani Duvuuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.